Novartis (NYSE:NVS) is jumping on the weight-loss bandwagon, aiming to develop next-generation anti-obesity drugs that could potentially address some of the drawbacks associated with current treatments.
https://seekingalpha.com/news/4068274-novartis-aiming-to-develop-next-generation-weight-loss-drugs
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.